Vizient has ranked Rush University Medical Center #1 for quality among the nation’s most prestigious academic medical centers. Learn more.

Excellence is just the beginning.


French German Italian Portuguese Russian

Systemic Lupus Erythematosus Prospective Observational Cohort Study

Clinical Trial Title: 
Systemic lupus erythematosus (SLE) prospective observational cohort study.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Ailda Nika, MD
Clinical Trial Protocol Description: 

The purpose of this observational study is to collect information about you to help describe the subject experience of living with SLE, by studying the clinical features of the disease, how the disease progresses, how it is treated and how it affects quality of life. Approximately 1500 subjects are expected to participate in this study, from approximately 151 sites across 8 countries. Ten subjects are expected to participate in this study at Rush University Medical Center.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are an adult patient ,18 years of age or older.
  • Have confirmation by a physician that you meet ACR (16) or SLICC (17) classification criteria for SLE.

You will be excluded from the study if any of the following criteria apply to you:

  • Have active severe lupus nephritis with a history of a renal biopsy in the last year.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Arthritis and Other Rheumatic Diseases
Contact Phone: 
(312) 563-2955
Contact Name: 
Joshlean Fair